Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.34 | 1e-17 |
mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.27 | 1e-11 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.27 | 5e-11 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.29 | 1e-09 |
mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.36 | 4e-09 |
mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.23 | 7e-09 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-08 |
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-08 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-08 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-08 |